Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Clinical trial NCT06957431 · RECRUITING
Trial details
- NCT number
- NCT06957431
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-22
- Primary completion
- 2031-05-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.